Biotime-Nasdaq's best kept secret? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotime-Nasdaq's best kept secret?

BTIM 0.0001000

0.0%

Nov 5 1:26 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Bill Wexler who wrote (714)	2/18/1998 8:01:00 PM
From: Jim Roof	Read Replies (1) of 1432

<<Thank you. Based on my analysis of the company, I consider it grossly overvalued.>> That was sarcasm of the highest order... sorry you missed it. I think you might also want to contact an attorney to see if what you are doing could legally be considered analysis. So far I have seen no analysis that is in any way relevant to your line of argumenation (the legal definition of argument may also be a question as it relates to your posts). <<The company has miniscule cash in the bank, no real assets, and its lead product candidate- Hextend, is not any better than Hespan.>> The company has 6,000,000 in cash and cash equivalents. Hextend was demonstrably better in the phase III trials (better cardiac function, less bleeding, less need to administer platelets and whole blood, not to mention that of the fluid study adverse SEVERE complications - 8 occurred with Hespan and only 2 with Hextend) <<Claims that Hextend will compete with albumin are ludicrous and false.>> That has about as much substance to it as Bill Clinton has moral character (get to kill two birds with one stone here). <<Hespan's market is relatively small - and there is really no reason to switch to Hextend.>> Relative to a fluid like Coca-Cola you are right. Read Crossen's analysis and you will see that there is a good market and it will be better when Hextend hits the market. I have already addressed Hextend's superiority over Hespan and other hetastarch colloids. <<Despite fraudulent claims by Biotime's management and various stock promoters, there is absolutely no reason to buy and hold this stock.>> Once again you make mention of fraudulent claims and I, once again, am asking for a specific instance of fraud. I am still waiting for anything to be offered here other than baseless reiterations of your empty claims. I have countered your arguments and have one to throw up to you again - If BTIM is a scam and/or is doomed to fail why are those who have the greatest and deepest knowledge of their product and research continuing to BUY and why have they not sold a single solitary share? Jim

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next